Ashley Lawton

ASHLEY LAWTON, President of Phylos, Inc., was previously Vice President,
Operations at Genzyme Corporation. He joined Phylos in August 1997.
Prior to his tenure with Genzyme, he served as Executive Vice President
and General Manager of Repligen Corporation and held senior management
positions with Celltech Biologics and Eli Lilly & Co. Ltd. He has an
established track record in managing biotechnology operations,
negotiating deals involving technology licensing and contract services,
and developing protein biopharmaceuticals. Dr. Lawton received his PhD
in Biochemistry from Southampton University, UK. He is also a graduate
of the Executive MBA Program of Boston University.